| Aktie | Ticker | 2025/Q4 | 2025/Q3 | 2025/Q2 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | ||
| 544.900.849 $ | +88.929.351 $ | +8,5 % | 455.971.498 $ | +247.398.591 $ | +90,1 % | 246.760.882 $ | +48.602.598 $ | -22,5 % | ||
| BANK OF AMERICA CORP /DE/ | BAC | 464.070.830 $ | +78.221.369 $ | +20,3 % | 385.849.461 $ | +209.662.617 $ | +119,0 % | 176.186.844 $ | +52.034.322 $ | +41,9 % |
| Jazz Pharmaceuticals plc | JAZZ | 42.171.900 $ | +2.551.502 $ | +6,4 % | 39.620.398 $ | +17.658.652 $ | +80,4 % | 21.961.746 $ | +21.961.746 $ | |
| Monopar Therapeutics | MNPR | 21.268.275 $ | +8.579.207 $ | +67,6 % | 12.689.068 $ | +12.689.068 $ | ||||
| Centessa Pharmaceuticals plc | CNTA | 7.070.127 $ | -10.742.444 $ | -60,3 % | 17.812.571 $ | +7.388.254 $ | +70,9 % | 10.424.317 $ | +3.972.126 $ | +61,6 % |
| MoonLake Immunotherapeutics | MLTX | 13.725.005 $ | +290.825 $ | +2,2 % | ||||||
| Oculis Holding AG | OCS | 10.319.717 $ | +10.319.717 $ | |||||||
| NEUROCRINE BIOSCIENCES INC | NBIX | 7.312.770 $ | +7.312.770 $ | |||||||
| Ascendis Pharma A/S | ASND | 6.591.767 $ | -24.465.520 $ | -78,8 % | ||||||
| ARGENX SE | ARGX | 5.669.298 $ | -2.535.135 $ | -30,9 % | ||||||
| Syndax Pharmaceuticals Inc | SNDX | 4.687.660 $ | -8.104.465 $ | -63,4 % | ||||||
| Silence Therapeutics plc | SLN | 201.475 $ | -1.864.071 $ | -90,2 % | ||||||
| 544.900.849 $ | +88.929.351 $ | +8,5 % | 455.971.498 $ | +247.398.591 $ | +90,1 % | 246.760.882 $ | +48.602.598 $ | -22,5 % | ||